Metastatic Carcinoid Tumors: A Clinical Review

Metastatic Carcinoid Tumors: A Clinical Review J. M. Zuetenhorst, B. G. Taal Oncologist 2005; 10: 123-131 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the epidemiology of carcinoid tumors and the survival rates observed in patients with different stages of disease. Discuss the diagnostic modalities available for assessing carcinoid tumors and be able to use the results of these studies to choose a treatment option. Summarize the current therapeutic options for the treatment of carcinoid tumors. Identify the importance of carcinoid heart disease (CHD) on prognosis in patients with carcinoid tumors. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 11, 2005 Most Recent Review: Feb. 11, 2005* Most Recent Update: Feb. 11, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.